Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08RDD
|
|||
| Drug Name |
PF-06823859
|
|||
| Indication | Dermatomycosis [ICD-11: EA60] | Phase 2 | [1] | |
| Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [2] | ||
| Lupus [ICD-11: 4A40; ICD-9: 710] | Phase 1 | [3] | ||
| Company |
Pfizer, New York, NY
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03181893) A Study In Adults With Moderate To Severe Dermatomyositis. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.